Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125907721 | 12590772 | 1 | I | 20160426 | 20160711 | 20160726 | 20160726 | EXP | DE-CIPLA LTD.-2016DE10001 | CIPLA | 0.00 | Y | 0.00000 | 20160726 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125907721 | 12590772 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 598.55 MG, EVERY 3 WEEKS | 77383 | 598.55 | MG | ||||||||
| 125907721 | 12590772 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 622.25 MG, UNK, EVERY 3 WEEKS | 77383 | 622.25 | MG | ||||||||
| 125907721 | 12590772 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 3 * 236.4 MG, EVERY 3 WEEKS | 0 | ||||||||||
| 125907721 | 12590772 | 4 | SS | Lonquex | LIPEGFILGRASTIM | 1 | Unknown | UNK | 0 | ||||||||||
| 125907721 | 12590772 | 5 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | Oral | 4 * 500 MG / TG, UNK | U | U | 0 | ||||||||
| 125907721 | 12590772 | 6 | C | Irbesartan / hct | 2 | Oral | 1 DF/ TG, UNK | U | U | 0 | |||||||||
| 125907721 | 12590772 | 7 | C | Targin | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Oral | 2 * 1 DF/ TG | U | U | 0 | ||||||||
| 125907721 | 12590772 | 8 | C | Bisoprolol | BISOPROLOL | 1 | Oral | 5 MG/ TG, UNK | U | U | 0 | ||||||||
| 125907721 | 12590772 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 100 MG/ TG. | U | U | 0 | ||||||||
| 125907721 | 12590772 | 10 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 8 MG/? | U | U | 0 | ||||||||
| 125907721 | 12590772 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 8 MG/? | U | U | 0 | ||||||||
| 125907721 | 12590772 | 12 | C | MCP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 10 MG AS NEEDED, UNK | U | U | 0 | 10 | MG | ||||||
| 125907721 | 12590772 | 13 | C | Potassium verla | 2 | Oral | 20 MMOL/ TG | U | U | 0 | |||||||||
| 125907721 | 12590772 | 14 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG/TG | U | U | 0 | ||||||||
| 125907721 | 12590772 | 15 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 2 X 850 MG/ TG | U | U | 0 | ||||||||
| 125907721 | 12590772 | 16 | C | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1 MG/? | U | U | 0 | ||||||||
| 125907721 | 12590772 | 17 | C | Ondansetron | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 8 MG/? | U | U | 0 | ||||||||
| 125907721 | 12590772 | 18 | C | Tazobac | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 3 X 4.5 L/TG | U | U | 0 | ||||||||
| 125907721 | 12590772 | 19 | C | Zopiclone | ZOPICLONE | 1 | Oral | 3.75 MG, PRN | U | U | 0 | 3.75 | MG | ||||||
| 125907721 | 12590772 | 20 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 150MG/ TG | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125907721 | 12590772 | 1 | Non-small cell lung cancer |
| 125907721 | 12590772 | 3 | Non-small cell lung cancer |
| 125907721 | 12590772 | 4 | Neutropenia |
| 125907721 | 12590772 | 5 | Pain |
| 125907721 | 12590772 | 6 | Hypertension |
| 125907721 | 12590772 | 7 | Pain |
| 125907721 | 12590772 | 8 | Hypertension |
| 125907721 | 12590772 | 9 | Prophylaxis |
| 125907721 | 12590772 | 10 | Nausea |
| 125907721 | 12590772 | 12 | Nausea |
| 125907721 | 12590772 | 13 | Hypokalaemia |
| 125907721 | 12590772 | 14 | Prophylaxis |
| 125907721 | 12590772 | 15 | Diabetes mellitus |
| 125907721 | 12590772 | 16 | Non-small cell lung cancer |
| 125907721 | 12590772 | 17 | Nausea |
| 125907721 | 12590772 | 18 | Infection |
| 125907721 | 12590772 | 19 | Sleep disorder |
| 125907721 | 12590772 | 20 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125907721 | 12590772 | DE |
| 125907721 | 12590772 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125907721 | 12590772 | Leukopenia | |
| 125907721 | 12590772 | Neutropenia | |
| 125907721 | 12590772 | Non-small cell lung cancer | |
| 125907721 | 12590772 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125907721 | 12590772 | 1 | 20160218 | 20160218 | 0 | |
| 125907721 | 12590772 | 2 | 20160309 | 20160420 | 0 | |
| 125907721 | 12590772 | 3 | 20160218 | 20160422 | 0 | |
| 125907721 | 12590772 | 4 | 20160225 | 20160424 | 0 | |
| 125907721 | 12590772 | 5 | 20160426 | 2016 | 0 | |
| 125907721 | 12590772 | 6 | 2016 | 0 | ||
| 125907721 | 12590772 | 7 | 20160426 | 2016 | 0 | |
| 125907721 | 12590772 | 8 | 2016 | 0 | ||
| 125907721 | 12590772 | 9 | 2016 | 0 | ||
| 125907721 | 12590772 | 10 | 20160218 | 2016 | 0 | |
| 125907721 | 12590772 | 11 | 20160221 | 2016 | 0 | |
| 125907721 | 12590772 | 12 | 20160309 | 2016 | 0 | |
| 125907721 | 12590772 | 13 | 20160307 | 2016 | 0 | |
| 125907721 | 12590772 | 14 | 20160216 | 2016 | 0 | |
| 125907721 | 12590772 | 15 | 2016 | 0 | ||
| 125907721 | 12590772 | 16 | 20160216 | 20160216 | 0 | |
| 125907721 | 12590772 | 17 | 20160218 | 2016 | 0 | |
| 125907721 | 12590772 | 18 | 20160501 | 201605 | 0 | |
| 125907721 | 12590772 | 19 | 20160310 | 2016 | 0 | |
| 125907721 | 12590772 | 20 | 2016 | 0 |